Major method-specific differences in the measurement of intact parathyroid hormone: Studies in patients with and without chronic renal failure

Annals of Clinical Biochemistry

Volumn 41, Issue 2, 2004, Pages 149-154

  Worth, G K ^a   Vasikaran, S D ^b,c   Retallackl, R W ^a   Musk, A A ^b   Gutteridge, D H ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ARTICLE; CALIBRATION; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSS REACTION; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; STANDARDIZATION;

HUMANS; IMMUNOASSAY; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 1942534029     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456304322880050     Document Type: Article

References (13)

1. Woodhead J. The measurement of circulating parathyroid hormone. Clin Biochem 1990; 23: 17-21
2. Brossard J-H, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996; 81: 3923-9
3. Lepage R, Roy L, Brossard J-H, et al. A non-(1-84) circulating hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998; 44: 805-9
4. Seth J, Sturgeon C, Ellis A, Al-Sadie R, Logan M. UK NEQAS for peptide hormones and related substances. Annual Review 1998, Dept Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh
5. Geigy Scientific Tables, vol. 2, 8th edition, Ed. C Lentner, 1982 p.214
6. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-10
7. Vasikaran S, Sturdy G, Musk A, Flicker L. Vitamin D insufficiency and hyperparathyroidism in Perth blood donors. Med J Aust 2000; 172: 406-7
8. Glendenning P, Vasikaran S. Vitamin D status and redefining serum PTH reference range in the elderly. J Clin Endocrinol Metab 2002; 87: 946-7
9. UK NEQAS for PTH, ACTH and Calcitonin, Distribution-77, 9 Sept. 2003
10. Ryan MF, Jones SR, Barnes AD. Modification to a commercial immunoradiometric assay permitting intraoperative monitoring of parathyroid hormone levels. Ann Clin Biochem 1990; 27: 65-8
11. Irvine GL, Desiro GT. A new practical intraoperative parathyroid hormone assay. Amer J Surg 1994; 168: 466-8
12. Irvine GL, Dembrow VD, Prudhomme DL. Surgery 1993; 114: 1019-23
13. Hilliker S, Wergedal J, Gruber H, Bettica P, Baylink D. Truncation of the amino terminus of PTH alters its anabolic action on bone in vivo. Bone 1996; 19: 467-77